Hyseq obtains patent rights for gene technology:
This article was originally published in Clinica
Hyseq has patented a gene sequence-assembling technology which allows researchers to investigate gene-related diseases, such as cancer and cardiovascular and infectious diseases, with greater speed and efficiency. The method is an automated technique for handling long sequences of genetic material, reducing the ambiguity of the current SBH technology. The US company is investigating a number of genes to determine their suitability for development into diagnostic and pharmaceutical products (see article on p 10).
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.